Alzheimer’s disease remains one of the most pressing challenges in modern medicine, ranking as a leading cause of death ...

The global pathological examination market is undergoing transformative growth, fueled by technological innovations, rising ...

Fulgent Genetics (NASDAQ:FLGT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a report released on Wednesday. Separately, Piper ...

The firm is engaging with regulators about its recently validated Ataraxis Breast test, which it hopes to make available for clinical use next year.

The Missouri hospital system designed its own 13-gene PGx panel, which it runs at its molecular genetics lab and calls the ...

Long before the rise of Rome, the Italian peninsula teemed with several different cultures, one of the most intriguing being ...

A large, multiyear study conducted by Illumina, Providence, and Microsoft Research has shown that a comprehensive genomic profiling (CGP) panel, which can assess more than 500 genetic variations in ...

SOPHiA GENETICS launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024: Boston, Massachusetts Saturday, November 23, 2024, 16:00 Hrs [IST] SOPHiA GENETICS, a cloud-native healthc ...

In this valuable study, the authors used an elegant genetic approach to delete EED at the post-neural crest induction stage. The usage of the single-cell RNA-seq analysis method is extremely suitable ...

Pancreatic cancer, a highly aggressive disease, often diagnosed late, has a low survival rate. Genetic testing provides ...

The POLAR genomic signature can help predict the patients with early breast cancer who may benefit from adjuvant radiotherapy ...